⌘K
Loading ticker…
As of 2026-08-24, BioNexus Gene Lab Corp Common stock (BGLC) has a 3-month relative strength percentile of 18 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 34. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.7%, relative volume 0.04×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
BGLC is in a stage 4 downtrend, week 9. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -12.8% / -42.5%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BGLC Jan avg: -0.01% median: -11.45% win: 33% σ: 41.19% n: 3 2023-07-21 → 2026-07-31 | BGLC Feb avg: 2.18% median: 4.90% win: 67% σ: 20.58% n: 3 2023-07-21 → 2026-07-31 | BGLC Mar avg: -8.39% median: -21.42% win: 33% σ: 28.28% n: 3 2023-07-21 → 2026-07-31 | BGLC Apr avg: 2.15% median: -1.90% win: 33% σ: 16.75% n: 3 2023-07-21 → 2026-07-31 | BGLC May avg: 9.84% median: 10.48% win: 67% σ: 41.00% n: 3 2023-07-21 → 2026-07-31 | BGLC Jun avg: -10.84% median: -15.95% win: 33% σ: 20.63% n: 3 2023-07-21 → 2026-07-31 | BGLC Jul avg: 10.46% median: -14.84% win: 50% σ: 80.33% n: 4 2023-07-21 → 2026-07-31 | BGLC Aug avg: -16.99% median: -18.04% win: 0% σ: 6.91% n: 3 2023-07-21 → 2026-07-31 (current) | BGLC Sep avg: -17.29% median: -3.70% win: 33% σ: 27.67% n: 3 2023-07-21 → 2026-07-31 | BGLC Oct avg: -23.95% median: -19.10% win: 0% σ: 25.81% n: 3 2023-07-21 → 2026-07-31 | BGLC Nov avg: 24.92% median: -16.24% win: 33% σ: 88.71% n: 3 2023-07-21 → 2026-07-31 | BGLC Dec avg: -12.09% median: -13.00% win: 33% σ: 32.58% n: 3 2023-07-21 → 2026-07-31 |